{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 7,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 2
      },
      "3": {
        "core": 1,
        "branch": 0
      },
      "4": {
        "core": 1,
        "branch": 0
      },
      "5": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A10 → G)",
        "prover9_expression": "(authorized_research(institution) -> drug_approved(drug_x))",
        "natural": "Provided that the institution is authorized for research, then drug X is approved."
      },
      {
        "id": "Rule2",
        "formal": "(A11 → G)",
        "prover9_expression": "(approved_funding(grant) -> drug_approved(drug_x))",
        "natural": "Under the condition that the grant has approved funding, drug X is approved."
      },
      {
        "id": "Rule3",
        "formal": "(A12 → A14)",
        "prover9_expression": "(passes_legislative_vote(bill_123) -> becomes_law(bill_123))",
        "natural": "Whenever bill 123 passes legislative vote, it becomes law."
      },
      {
        "id": "Rule4",
        "formal": "(A12 ∨ A13)",
        "prover9_expression": "(passes_legislative_vote(bill_123) | executive_approval(president))",
        "natural": "Either bill 123 passes legislative vote or the president grants executive approval."
      },
      {
        "id": "Rule5",
        "formal": "(A13 → A11)",
        "prover9_expression": "(executive_approval(president) -> approved_funding(grant))",
        "natural": "Provided that the president grants executive approval, then the grant has approved funding."
      },
      {
        "id": "Rule6",
        "formal": "(A14 → A16)",
        "prover9_expression": "(becomes_law(bill_123) -> establishes_guidelines(fda))",
        "natural": "Whenever bill 123 becomes law, the FDA establishes guidelines."
      },
      {
        "id": "Rule7",
        "formal": "(A15 → A10)",
        "prover9_expression": "(creates_agency(fda) -> authorized_research(institution))",
        "natural": "If the FDA is created as an agency, then the institution is authorized for research."
      },
      {
        "id": "Rule8",
        "formal": "(A16 → A15)",
        "prover9_expression": "(establishes_guidelines(fda) -> creates_agency(fda))",
        "natural": "Provided that the FDA establishes guidelines, then the FDA is created as an agency."
      },
      {
        "id": "Rule9",
        "formal": "(A18 → G)",
        "prover9_expression": "(exclusive_rights(pharma_company) -> drug_approved(drug_x))",
        "natural": "If the pharma company has exclusive rights, then drug X is approved."
      },
      {
        "id": "Rule10",
        "formal": "(A19 → A20)",
        "prover9_expression": "(illegal_import(supplier) -> registered_importer(supplier))",
        "natural": "Provided that the supplier engages in illegal import, then the supplier is a registered importer."
      },
      {
        "id": "Rule11",
        "formal": "(A19 → A23)",
        "prover9_expression": "(illegal_import(supplier) -> criminal_charges(filed))",
        "natural": "Whenever the supplier engages in illegal import, criminal charges are filed."
      },
      {
        "id": "Rule12",
        "formal": "(A19 ∨ (A17 → A18))",
        "prover9_expression": "(illegal_import(supplier) | (has_patent(pharma_company) -> exclusive_rights(pharma_company)))",
        "natural": "Either the supplier engages in illegal import or, if the pharma company has a patent, then it has exclusive rights."
      },
      {
        "id": "Rule13",
        "formal": "(A21 → ¬A20)",
        "prover9_expression": "(customs_seizure(shipment) -> -registered_importer(supplier))",
        "natural": "Under the condition that the shipment is subject to customs seizure, then the supplier is not a registered importer."
      },
      {
        "id": "Rule14",
        "formal": "(A22 → A21)",
        "prover9_expression": "(investigation_opened(fbi) -> customs_seizure(shipment))",
        "natural": "If the FBI opens an investigation, then the shipment is subject to customs seizure."
      },
      {
        "id": "Rule15",
        "formal": "(A23 → A22)",
        "prover9_expression": "(criminal_charges(filed) -> investigation_opened(fbi))",
        "natural": "Provided that criminal charges are filed, then the FBI opens an investigation."
      },
      {
        "id": "Rule16",
        "formal": "(A24 ∨ A25)",
        "prover9_expression": "(clinical_trial_phase(completed) | peer_review_passed(study))",
        "natural": "Either the clinical trial phase is completed or the study passes peer review."
      },
      {
        "id": "Rule17",
        "formal": "(A25 → G)",
        "prover9_expression": "(peer_review_passed(study) -> drug_approved(drug_x))",
        "natural": "Whenever the study passes peer review, drug X is approved."
      },
      {
        "id": "Rule18",
        "formal": "(A26 → (A24 → G))",
        "prover9_expression": "(data_audit(independent) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
        "natural": "If an independent data audit is conducted, then, provided that the clinical trial phase is completed, drug X is approved."
      },
      {
        "id": "Rule19",
        "formal": "(A27 → (A24 → G))",
        "prover9_expression": "(statistical_analysis(valid) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
        "natural": "Under the condition that the statistical analysis is valid, then, if the clinical trial phase is completed, drug X is approved."
      },
      {
        "id": "Rule20",
        "formal": "(A28 → A26)",
        "prover9_expression": "(monitoring_committee(review) -> data_audit(independent))",
        "natural": "Provided that the monitoring committee conducts a review, then an independent data audit is conducted."
      },
      {
        "id": "Rule21",
        "formal": "(A28 ∨ A29)",
        "prover9_expression": "(monitoring_committee(review) | adverse_events(reported))",
        "natural": "Either the monitoring committee conducts a review or adverse events are reported."
      },
      {
        "id": "Rule22",
        "formal": "(A30 → A27)",
        "prover9_expression": "(safety_assessment(completed) -> statistical_analysis(valid))",
        "natural": "Under the condition that a safety assessment is completed, then the statistical analysis is valid."
      },
      {
        "id": "Rule23",
        "formal": "(A32 → A31)",
        "prover9_expression": "(protocol_amendment(required) -> trial_suspended(temporarily))",
        "natural": "Provided that a protocol amendment is required, then the trial is suspended temporarily."
      },
      {
        "id": "Rule24",
        "formal": "(A33 → (¬(A29 → A30) → A32))",
        "prover9_expression": "(dsmb_recommendation(issued) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
        "natural": "If a DSMB recommendation is issued, then, under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required."
      },
      {
        "id": "Rule25",
        "formal": "(A33 ∨ A34)",
        "prover9_expression": "(dsmb_recommendation(issued) | regulatory_inspection(fda))",
        "natural": "Either a DSMB recommendation is issued or the FDA conducts a regulatory inspection."
      },
      {
        "id": "Rule26",
        "formal": "(A34 → (¬(A29 → A30) → A32))",
        "prover9_expression": "(regulatory_inspection(fda) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
        "natural": "Whenever the FDA conducts a regulatory inspection, then, provided that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required."
      },
      {
        "id": "Rule27",
        "formal": "(A36 ∨ ¬A35)",
        "prover9_expression": "(quality_control_check(failed) | -manufacturing_complaint(received))",
        "natural": "Either the quality control check fails or it is not the case that a manufacturing complaint is received."
      },
      {
        "id": "Rule28",
        "formal": "(A37 ∨ ¬A36)",
        "prover9_expression": "(batch_recall(initiated) | -quality_control_check(failed))",
        "natural": "Either a batch recall is initiated or it is not the case that the quality control check fails."
      },
      {
        "id": "Rule29",
        "formal": "(A38 ∨ ¬A37)",
        "prover9_expression": "(production_halted(facility) | -batch_recall(initiated))",
        "natural": "Either production is halted at the facility or it is not the case that a batch recall is initiated."
      },
      {
        "id": "Rule30",
        "formal": "(A39 → ¬A8)",
        "prover9_expression": "(false_claim_made(company) -> -violates_regulation(company))",
        "natural": "If the company makes a false claim, then it is not the case that the company violates a regulation."
      },
      {
        "id": "Rule31",
        "formal": "(A42 → (¬(¬A39 → A40) → A41))",
        "prover9_expression": "(whistleblower_report(submitted) -> (-(-false_claim_made(company) -> corrective_action(taken)) -> warning_letter(issued)))",
        "natural": "Provided that a whistleblower report is submitted, then, under the condition that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, a warning letter is issued."
      },
      {
        "id": "Rule32",
        "formal": "(A5 → (¬(¬(¬(¬G → A1) → A2) → ¬A3) → A4))",
        "prover9_expression": "(is_scheduled(hearing) -> (-(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee)) -> gets_market_approval(drug_x)))",
        "natural": "If a hearing is scheduled, then, under the condition that it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, drug X gets market approval."
      },
      {
        "id": "Rule33",
        "formal": "(A8 → A9)",
        "prover9_expression": "(violates_regulation(company) -> pays_fine(company))",
        "natural": "Whenever the company violates a regulation, then the company pays a fine."
      },
      {
        "id": "Rule34",
        "formal": "(A8 → ¬A9)",
        "prover9_expression": "(violates_regulation(company) -> -pays_fine(company))",
        "natural": "Under the condition that the company violates a regulation, then it is not the case that the company pays a fine."
      },
      {
        "id": "Rule35",
        "formal": "(A8 ∨ (A7 ∨ (¬G → ¬A6)))",
        "prover9_expression": "(violates_regulation(company) | (submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))))",
        "natural": "Either the company violates a regulation or either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
      },
      {
        "id": "Rule36",
        "formal": "(¬(A29 → A30) → ¬A31)",
        "prover9_expression": "(-(adverse_events(reported) -> safety_assessment(completed)) -> -trial_suspended(temporarily))",
        "natural": "Under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, then it is not the case that the trial is suspended temporarily."
      },
      {
        "id": "Rule37",
        "formal": "(¬(A7 ∨ (¬G → ¬A6)) → A35)",
        "prover9_expression": "(-(submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))) -> manufacturing_complaint(received))",
        "natural": "Provided that it is not the case that either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing, then a manufacturing complaint is received."
      },
      {
        "id": "Rule38",
        "formal": "(¬(¬(¬G → A1) → A2) → A3)",
        "prover9_expression": "(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> passes_review(committee))",
        "natural": "Under the condition that it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then the committee passes review."
      },
      {
        "id": "Rule39",
        "formal": "(¬A39 → ¬A40)",
        "prover9_expression": "(-false_claim_made(company) -> -corrective_action(taken))",
        "natural": "Whenever it is not the case that the company makes a false claim, then it is not the case that corrective action is taken."
      },
      {
        "id": "Rule40",
        "formal": "(¬G → A6)",
        "prover9_expression": "(-drug_approved(drug_x) -> completes_testing(lab))",
        "natural": "If drug X is not approved, then the lab completes testing."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A17",
        "prover9_expression": "has_patent(pharma_company)",
        "natural": "The pharma company has a patent."
      },
      {
        "id": "Fact2",
        "formal": "A42",
        "prover9_expression": "whistleblower_report(submitted)",
        "natural": "A whistleblower report is submitted."
      },
      {
        "id": "Fact3",
        "formal": "A5",
        "prover9_expression": "is_scheduled(hearing)",
        "natural": "A hearing is scheduled."
      },
      {
        "id": "Fact4",
        "formal": "¬A1",
        "prover9_expression": "-requires_approval(clinical_trial)",
        "natural": "It is not the case that clinical trials require approval."
      },
      {
        "id": "Fact5",
        "formal": "¬A2",
        "prover9_expression": "-has_safety_data(drug_x)",
        "natural": "It is not the case that drug X has safety data."
      },
      {
        "id": "Fact6",
        "formal": "¬A38",
        "prover9_expression": "-production_halted(facility)",
        "natural": "It is not the case that production is halted at the facility."
      },
      {
        "id": "Fact7",
        "formal": "¬A4",
        "prover9_expression": "-gets_market_approval(drug_x)",
        "natural": "It is not the case that drug X gets market approval."
      },
      {
        "id": "Fact8",
        "formal": "¬A41",
        "prover9_expression": "-warning_letter(issued)",
        "natural": "It is not the case that a warning letter is issued."
      },
      {
        "id": "Fact9",
        "formal": "¬A7",
        "prover9_expression": "-submits_report(manufacturer)",
        "natural": "It is not the case that the manufacturer submits a report."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "drug_approved(drug_x)",
    "natural": "Drug X is approved."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A5 -> (-(-(-(-G -> A1) -> A2) -> -A3) -> A4))",
            "A5"
          ],
          "conclusion": "(-(-(-(-G -> A1) -> A2) -> -A3) -> A4)",
          "natural": "If it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, then drug X gets market approval."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(-(-G -> A1) -> A2) -> -A3) -> A4)",
            "-A4"
          ],
          "conclusion": "(-(-(-G -> A1) -> A2) -> -A3)",
          "natural": "Whenever it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then it is not the case that the committee passes review."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-G -> A1) -> A2) -> A3)",
            "(-(-(-G -> A1) -> A2) -> -A3)"
          ],
          "conclusion": "(-(-G -> A1) -> A2)",
          "natural": "If it is not the case that if drug X is approved then clinical trials require approval, then drug X has safety data."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-G -> A1) -> A2)",
            "-A2"
          ],
          "conclusion": "(-G -> A1)",
          "natural": "Provided that drug X is not approved, then clinical trials require approval."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(A8 -> A9)",
            "(A8 -> -A9)"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that the company violates a regulation."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | (A7 | (-G -> -A6)))",
            "-A8"
          ],
          "conclusion": "(A7 | (-G -> -A6))",
          "natural": "Either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | (-G -> -A6))",
            "-A7"
          ],
          "conclusion": "(-G -> -A6)",
          "natural": "Under the condition that drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A6)",
            "(-G -> -A6)"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A14 -> A16)",
            "(A16 -> A15)"
          ],
          "conclusion": "(A14 -> A15)",
          "natural": "Under the condition that bill 123 becomes law, the FDA is created as an agency."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A14 -> A15)",
            "(A15 -> A10)"
          ],
          "conclusion": "(A14 -> A10)",
          "natural": "If bill 123 becomes law, then the institution is authorized for research."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A12 -> A14)",
            "(A14 -> A10)"
          ],
          "conclusion": "(A12 -> A10)",
          "natural": "If bill 123 passes legislative vote, then the institution is authorized for research."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A12 -> A10)",
            "(A13 -> A11)",
            "(A12 | A13)"
          ],
          "conclusion": "(A10 | A11)",
          "natural": "Either the institution is authorized for research or the grant has approved funding."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A10 | A11)",
            "(A10 -> G)",
            "(A11 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A23)",
            "(A23 -> A22)"
          ],
          "conclusion": "(A19 -> A22)",
          "natural": "If the supplier engages in illegal import, then the FBI opens an investigation."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A22)",
            "(A22 -> A21)"
          ],
          "conclusion": "(A19 -> A21)",
          "natural": "Under the condition that the supplier engages in illegal import, the shipment is subject to customs seizure."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A21)",
            "(A21 -> -A20)"
          ],
          "conclusion": "(A19 -> -A20)",
          "natural": "Provided that the supplier engages in illegal import, then it is not the case that the supplier is a registered importer."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A19 -> A20)",
            "(A19 -> -A20)"
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that the supplier engages in illegal import."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 -> A18))",
            "-A19"
          ],
          "conclusion": "(A17 -> A18)",
          "natural": "Under the condition that the pharma company has a patent, it has exclusive rights."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(A17 -> A18)",
            "(A18 -> G)"
          ],
          "conclusion": "(A17 -> G)",
          "natural": "Whenever the pharma company has a patent, drug X is approved."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A17 -> G)",
            "A17"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A33 | A34)",
            "(A33 -> (-(A29 -> A30) -> A32))",
            "(A34 -> (-(A29 -> A30) -> A32))"
          ],
          "conclusion": "(-(A29 -> A30) -> A32)",
          "natural": "If it is not the case that if adverse events are reported then a safety assessment is completed, then a protocol amendment is required."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A29 -> A30) -> A32)",
            "(A32 -> A31)"
          ],
          "conclusion": "(-(A29 -> A30) -> A31)",
          "natural": "Provided that it is not the case that if adverse events are reported then a safety assessment is completed, then the trial is suspended temporarily."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A29 -> A30) -> A31)",
            "(-(A29 -> A30) -> -A31)"
          ],
          "conclusion": "(A29 -> A30)",
          "natural": "Whenever adverse events are reported, a safety assessment is completed."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A29 -> A30)",
            "(A30 -> A27)"
          ],
          "conclusion": "(A29 -> A27)",
          "natural": "If adverse events are reported, then the statistical analysis is valid."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A28 -> A26)",
            "(A29 -> A27)",
            "(A28 | A29)"
          ],
          "conclusion": "(A26 | A27)",
          "natural": "Either an independent data audit is conducted or the statistical analysis is valid."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A26 | A27)",
            "(A26 -> (A24 -> G))",
            "(A27 -> (A24 -> G))"
          ],
          "conclusion": "(A24 -> G)",
          "natural": "Under the condition that the clinical trial phase is completed, then drug X is approved."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> G)",
            "(A25 -> G)"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A38 | -A37)",
            "-A38"
          ],
          "conclusion": "-A37",
          "natural": "It is not the case that a batch recall is initiated."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A37 | -A36)",
            "-A37"
          ],
          "conclusion": "-A36",
          "natural": "It is not the case that the quality control check fails."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A36 | -A35)",
            "-A36"
          ],
          "conclusion": "-A35",
          "natural": "It is not the case that a manufacturing complaint is received."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A7 | (-G -> -A6)) -> A35)",
            "-A35"
          ],
          "conclusion": "(A7 | (-G -> -A6))",
          "natural": "Either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | (-G -> -A6))",
            "-A7"
          ],
          "conclusion": "(-G -> -A6)",
          "natural": "Under the condition that drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A6)",
            "(-G -> -A6)"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A42 -> (-(-A39 -> A40) -> A41))",
            "A42"
          ],
          "conclusion": "(-(-A39 -> A40) -> A41)",
          "natural": "Provided that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, then a warning letter is issued."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-A39 -> A40) -> A41)",
            "-A41"
          ],
          "conclusion": "(-A39 -> A40)",
          "natural": "Under the condition that it is not the case that the company makes a false claim, then corrective action is taken."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A39 -> A40)",
            "(-A39 -> -A40)"
          ],
          "conclusion": "A39",
          "natural": "The company makes a false claim."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A39 -> -A8)",
            "A39"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that the company violates a regulation."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | (A7 | (-G -> -A6)))",
            "-A8"
          ],
          "conclusion": "(A7 | (-G -> -A6))",
          "natural": "Either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | (-G -> -A6))",
            "-A7"
          ],
          "conclusion": "(-G -> -A6)",
          "natural": "Under the condition that drug X is not approved, then it is not the case that the lab completes testing."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A6)",
            "(-G -> -A6)"
          ],
          "conclusion": "G",
          "natural": "Drug X is approved."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Regulation",
    "atomic_facts": {
      "A1": "requires_approval(clinical_trial)",
      "A2": "has_safety_data(drug_x)",
      "A3": "passes_review(committee)",
      "A4": "gets_market_approval(drug_x)",
      "A5": "is_scheduled(hearing)",
      "A6": "completes_testing(lab)",
      "A7": "submits_report(manufacturer)",
      "A8": "violates_regulation(company)",
      "A9": "pays_fine(company)",
      "A10": "authorized_research(institution)",
      "A11": "approved_funding(grant)",
      "A12": "passes_legislative_vote(bill_123)",
      "A13": "executive_approval(president)",
      "A14": "becomes_law(bill_123)",
      "A15": "creates_agency(fda)",
      "A16": "establishes_guidelines(fda)",
      "A17": "has_patent(pharma_company)",
      "A18": "exclusive_rights(pharma_company)",
      "A19": "illegal_import(supplier)",
      "A20": "registered_importer(supplier)",
      "A21": "customs_seizure(shipment)",
      "A22": "investigation_opened(fbi)",
      "A23": "criminal_charges(filed)",
      "A24": "clinical_trial_phase(completed)",
      "A25": "peer_review_passed(study)",
      "A26": "data_audit(independent)",
      "A27": "statistical_analysis(valid)",
      "A28": "monitoring_committee(review)",
      "A29": "adverse_events(reported)",
      "A30": "safety_assessment(completed)",
      "A31": "trial_suspended(temporarily)",
      "A32": "protocol_amendment(required)",
      "A33": "dsmb_recommendation(issued)",
      "A34": "regulatory_inspection(fda)",
      "A35": "manufacturing_complaint(received)",
      "A36": "quality_control_check(failed)",
      "A37": "batch_recall(initiated)",
      "A38": "production_halted(facility)",
      "A39": "false_claim_made(company)",
      "A40": "corrective_action(taken)",
      "A41": "warning_letter(issued)",
      "A42": "whistleblower_report(submitted)",
      "G": "drug_approved(drug_x)"
    },
    "natural_facts": {
      "A1": "Clinical trials require approval.",
      "A2": "Drug X has safety data.",
      "A3": "The committee passes review.",
      "A4": "Drug X gets market approval.",
      "A5": "A hearing is scheduled.",
      "A6": "The lab completes testing.",
      "A7": "The manufacturer submits a report.",
      "A8": "The company violates a regulation.",
      "A9": "The company pays a fine.",
      "A10": "The institution is authorized for research.",
      "A11": "The grant has approved funding.",
      "A12": "Bill 123 passes legislative vote.",
      "A13": "The president grants executive approval.",
      "A14": "Bill 123 becomes law.",
      "A15": "The FDA is created as an agency.",
      "A16": "The FDA establishes guidelines.",
      "A17": "The pharma company has a patent.",
      "A18": "The pharma company has exclusive rights.",
      "A19": "The supplier engages in illegal import.",
      "A20": "The supplier is a registered importer.",
      "A21": "The shipment is subject to customs seizure.",
      "A22": "The FBI opens an investigation.",
      "A23": "Criminal charges are filed.",
      "A24": "The clinical trial phase is completed.",
      "A25": "The study passes peer review.",
      "A26": "An independent data audit is conducted.",
      "A27": "The statistical analysis is valid.",
      "A28": "The monitoring committee conducts a review.",
      "A29": "Adverse events are reported.",
      "A30": "A safety assessment is completed.",
      "A31": "The trial is suspended temporarily.",
      "A32": "A protocol amendment is required.",
      "A33": "A DSMB recommendation is issued.",
      "A34": "The FDA conducts a regulatory inspection.",
      "A35": "A manufacturing complaint is received.",
      "A36": "The quality control check fails.",
      "A37": "A batch recall is initiated.",
      "A38": "Production is halted at the facility.",
      "A39": "The company makes a false claim.",
      "A40": "Corrective action is taken.",
      "A41": "A warning letter is issued.",
      "A42": "A whistleblower report is submitted.",
      "G": "Drug X is approved."
    },
    "prover9_expressions": [
      "(authorized_research(institution) -> drug_approved(drug_x))",
      "(authorized_research(institution) | approved_funding(grant))",
      "(approved_funding(grant) -> drug_approved(drug_x))",
      "(passes_legislative_vote(bill_123) -> authorized_research(institution))",
      "(passes_legislative_vote(bill_123) -> becomes_law(bill_123))",
      "(passes_legislative_vote(bill_123) | executive_approval(president))",
      "(executive_approval(president) -> approved_funding(grant))",
      "(becomes_law(bill_123) -> authorized_research(institution))",
      "(becomes_law(bill_123) -> creates_agency(fda))",
      "(becomes_law(bill_123) -> establishes_guidelines(fda))",
      "(creates_agency(fda) -> authorized_research(institution))",
      "(establishes_guidelines(fda) -> creates_agency(fda))",
      "(has_patent(pharma_company) -> exclusive_rights(pharma_company))",
      "(has_patent(pharma_company) -> drug_approved(drug_x))",
      "(exclusive_rights(pharma_company) -> drug_approved(drug_x))",
      "(illegal_import(supplier) -> registered_importer(supplier))",
      "(illegal_import(supplier) -> customs_seizure(shipment))",
      "(illegal_import(supplier) -> investigation_opened(fbi))",
      "(illegal_import(supplier) -> criminal_charges(filed))",
      "(illegal_import(supplier) -> -registered_importer(supplier))",
      "(illegal_import(supplier) | (has_patent(pharma_company) -> exclusive_rights(pharma_company)))",
      "(customs_seizure(shipment) -> -registered_importer(supplier))",
      "(investigation_opened(fbi) -> customs_seizure(shipment))",
      "(criminal_charges(filed) -> investigation_opened(fbi))",
      "(clinical_trial_phase(completed) -> drug_approved(drug_x))",
      "(clinical_trial_phase(completed) | peer_review_passed(study))",
      "(peer_review_passed(study) -> drug_approved(drug_x))",
      "(data_audit(independent) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
      "(data_audit(independent) | statistical_analysis(valid))",
      "(statistical_analysis(valid) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
      "(monitoring_committee(review) -> data_audit(independent))",
      "(monitoring_committee(review) | adverse_events(reported))",
      "(adverse_events(reported) -> statistical_analysis(valid))",
      "(adverse_events(reported) -> safety_assessment(completed))",
      "(safety_assessment(completed) -> statistical_analysis(valid))",
      "(protocol_amendment(required) -> trial_suspended(temporarily))",
      "(dsmb_recommendation(issued) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
      "(dsmb_recommendation(issued) | regulatory_inspection(fda))",
      "(regulatory_inspection(fda) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
      "(quality_control_check(failed) | -manufacturing_complaint(received))",
      "(batch_recall(initiated) | -quality_control_check(failed))",
      "(production_halted(facility) | -batch_recall(initiated))",
      "(false_claim_made(company) -> -violates_regulation(company))",
      "(whistleblower_report(submitted) -> (-(-false_claim_made(company) -> corrective_action(taken)) -> warning_letter(issued)))",
      "(is_scheduled(hearing) -> (-(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee)) -> gets_market_approval(drug_x)))",
      "(submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab)))",
      "(violates_regulation(company) -> pays_fine(company))",
      "(violates_regulation(company) -> -pays_fine(company))",
      "(violates_regulation(company) | (submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))))",
      "(-(adverse_events(reported) -> safety_assessment(completed)) -> trial_suspended(temporarily))",
      "(-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required))",
      "(-(adverse_events(reported) -> safety_assessment(completed)) -> -trial_suspended(temporarily))",
      "(-(submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))) -> manufacturing_complaint(received))",
      "(-(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee)) -> gets_market_approval(drug_x))",
      "(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> passes_review(committee))",
      "(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee))",
      "(-(-false_claim_made(company) -> corrective_action(taken)) -> warning_letter(issued))",
      "(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x))",
      "(-false_claim_made(company) -> corrective_action(taken))",
      "(-false_claim_made(company) -> -corrective_action(taken))",
      "(-drug_approved(drug_x) -> requires_approval(clinical_trial))",
      "(-drug_approved(drug_x) -> completes_testing(lab))",
      "(-drug_approved(drug_x) -> -completes_testing(lab))",
      "has_patent(pharma_company)",
      "false_claim_made(company)",
      "whistleblower_report(submitted)",
      "is_scheduled(hearing)",
      "drug_approved(drug_x)",
      "-requires_approval(clinical_trial)",
      "-illegal_import(supplier)",
      "-has_safety_data(drug_x)",
      "-manufacturing_complaint(received)",
      "-quality_control_check(failed)",
      "-batch_recall(initiated)",
      "-production_halted(facility)",
      "-gets_market_approval(drug_x)",
      "-warning_letter(issued)",
      "-submits_report(manufacturer)",
      "-violates_regulation(company)"
    ],
    "natural_expressions": [
      "Provided that the institution is authorized for research, then drug X is approved.",
      "Either the institution is authorized for research or the grant has approved funding.",
      "Under the condition that the grant has approved funding, drug X is approved.",
      "If bill 123 passes legislative vote, then the institution is authorized for research.",
      "Whenever bill 123 passes legislative vote, it becomes law.",
      "Either bill 123 passes legislative vote or the president grants executive approval.",
      "Provided that the president grants executive approval, then the grant has approved funding.",
      "If bill 123 becomes law, then the institution is authorized for research.",
      "Under the condition that bill 123 becomes law, the FDA is created as an agency.",
      "Whenever bill 123 becomes law, the FDA establishes guidelines.",
      "If the FDA is created as an agency, then the institution is authorized for research.",
      "Provided that the FDA establishes guidelines, then the FDA is created as an agency.",
      "Under the condition that the pharma company has a patent, it has exclusive rights.",
      "Whenever the pharma company has a patent, drug X is approved.",
      "If the pharma company has exclusive rights, then drug X is approved.",
      "Provided that the supplier engages in illegal import, then the supplier is a registered importer.",
      "Under the condition that the supplier engages in illegal import, the shipment is subject to customs seizure.",
      "If the supplier engages in illegal import, then the FBI opens an investigation.",
      "Whenever the supplier engages in illegal import, criminal charges are filed.",
      "Provided that the supplier engages in illegal import, then it is not the case that the supplier is a registered importer.",
      "Either the supplier engages in illegal import or, if the pharma company has a patent, then it has exclusive rights.",
      "Under the condition that the shipment is subject to customs seizure, then the supplier is not a registered importer.",
      "If the FBI opens an investigation, then the shipment is subject to customs seizure.",
      "Provided that criminal charges are filed, then the FBI opens an investigation.",
      "Under the condition that the clinical trial phase is completed, then drug X is approved.",
      "Either the clinical trial phase is completed or the study passes peer review.",
      "Whenever the study passes peer review, drug X is approved.",
      "If an independent data audit is conducted, then, provided that the clinical trial phase is completed, drug X is approved.",
      "Either an independent data audit is conducted or the statistical analysis is valid.",
      "Under the condition that the statistical analysis is valid, then, if the clinical trial phase is completed, drug X is approved.",
      "Provided that the monitoring committee conducts a review, then an independent data audit is conducted.",
      "Either the monitoring committee conducts a review or adverse events are reported.",
      "If adverse events are reported, then the statistical analysis is valid.",
      "Whenever adverse events are reported, a safety assessment is completed.",
      "Under the condition that a safety assessment is completed, then the statistical analysis is valid.",
      "Provided that a protocol amendment is required, then the trial is suspended temporarily.",
      "If a DSMB recommendation is issued, then, under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required.",
      "Either a DSMB recommendation is issued or the FDA conducts a regulatory inspection.",
      "Whenever the FDA conducts a regulatory inspection, then, provided that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required.",
      "Either the quality control check fails or it is not the case that a manufacturing complaint is received.",
      "Either a batch recall is initiated or it is not the case that the quality control check fails.",
      "Either production is halted at the facility or it is not the case that a batch recall is initiated.",
      "If the company makes a false claim, then it is not the case that the company violates a regulation.",
      "Provided that a whistleblower report is submitted, then, under the condition that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, a warning letter is issued.",
      "If a hearing is scheduled, then, under the condition that it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, drug X gets market approval.",
      "Either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing.",
      "Whenever the company violates a regulation, then the company pays a fine.",
      "Under the condition that the company violates a regulation, then it is not the case that the company pays a fine.",
      "Either the company violates a regulation or either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing.",
      "Provided that it is not the case that if adverse events are reported then a safety assessment is completed, then the trial is suspended temporarily.",
      "If it is not the case that if adverse events are reported then a safety assessment is completed, then a protocol amendment is required.",
      "Under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, then it is not the case that the trial is suspended temporarily.",
      "Provided that it is not the case that either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing, then a manufacturing complaint is received.",
      "If it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, then drug X gets market approval.",
      "Under the condition that it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then the committee passes review.",
      "Whenever it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then it is not the case that the committee passes review.",
      "Provided that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, then a warning letter is issued.",
      "If it is not the case that if drug X is approved then clinical trials require approval, then drug X has safety data.",
      "Under the condition that it is not the case that the company makes a false claim, then corrective action is taken.",
      "Whenever it is not the case that the company makes a false claim, then it is not the case that corrective action is taken.",
      "Provided that drug X is not approved, then clinical trials require approval.",
      "If drug X is not approved, then the lab completes testing.",
      "Under the condition that drug X is not approved, then it is not the case that the lab completes testing.",
      "The pharma company has a patent.",
      "The company makes a false claim.",
      "A whistleblower report is submitted.",
      "A hearing is scheduled.",
      "Drug X is approved.",
      "It is not the case that clinical trials require approval.",
      "It is not the case that the supplier engages in illegal import.",
      "It is not the case that drug X has safety data.",
      "It is not the case that a manufacturing complaint is received.",
      "It is not the case that the quality control check fails.",
      "It is not the case that a batch recall is initiated.",
      "It is not the case that production is halted at the facility.",
      "It is not the case that drug X gets market approval.",
      "It is not the case that a warning letter is issued.",
      "It is not the case that the manufacturer submits a report.",
      "It is not the case that the company violates a regulation."
    ],
    "node_mappings": {
      "(A10 → G)": {
        "formal": "(A10 → G)",
        "prover9": "(A10 -> G)",
        "prover9_expression": "(authorized_research(institution) -> drug_approved(drug_x))",
        "natural": "Provided that the institution is authorized for research, then drug X is approved."
      },
      "(A10 ∨ A11)": {
        "formal": "(A10 ∨ A11)",
        "prover9": "(A10 | A11)",
        "prover9_expression": "(authorized_research(institution) | approved_funding(grant))",
        "natural": "Either the institution is authorized for research or the grant has approved funding."
      },
      "(A11 → G)": {
        "formal": "(A11 → G)",
        "prover9": "(A11 -> G)",
        "prover9_expression": "(approved_funding(grant) -> drug_approved(drug_x))",
        "natural": "Under the condition that the grant has approved funding, drug X is approved."
      },
      "(A12 → A10)": {
        "formal": "(A12 → A10)",
        "prover9": "(A12 -> A10)",
        "prover9_expression": "(passes_legislative_vote(bill_123) -> authorized_research(institution))",
        "natural": "If bill 123 passes legislative vote, then the institution is authorized for research."
      },
      "(A12 → A14)": {
        "formal": "(A12 → A14)",
        "prover9": "(A12 -> A14)",
        "prover9_expression": "(passes_legislative_vote(bill_123) -> becomes_law(bill_123))",
        "natural": "Whenever bill 123 passes legislative vote, it becomes law."
      },
      "(A12 ∨ A13)": {
        "formal": "(A12 ∨ A13)",
        "prover9": "(A12 | A13)",
        "prover9_expression": "(passes_legislative_vote(bill_123) | executive_approval(president))",
        "natural": "Either bill 123 passes legislative vote or the president grants executive approval."
      },
      "(A13 → A11)": {
        "formal": "(A13 → A11)",
        "prover9": "(A13 -> A11)",
        "prover9_expression": "(executive_approval(president) -> approved_funding(grant))",
        "natural": "Provided that the president grants executive approval, then the grant has approved funding."
      },
      "(A14 → A10)": {
        "formal": "(A14 → A10)",
        "prover9": "(A14 -> A10)",
        "prover9_expression": "(becomes_law(bill_123) -> authorized_research(institution))",
        "natural": "If bill 123 becomes law, then the institution is authorized for research."
      },
      "(A14 → A15)": {
        "formal": "(A14 → A15)",
        "prover9": "(A14 -> A15)",
        "prover9_expression": "(becomes_law(bill_123) -> creates_agency(fda))",
        "natural": "Under the condition that bill 123 becomes law, the FDA is created as an agency."
      },
      "(A14 → A16)": {
        "formal": "(A14 → A16)",
        "prover9": "(A14 -> A16)",
        "prover9_expression": "(becomes_law(bill_123) -> establishes_guidelines(fda))",
        "natural": "Whenever bill 123 becomes law, the FDA establishes guidelines."
      },
      "(A15 → A10)": {
        "formal": "(A15 → A10)",
        "prover9": "(A15 -> A10)",
        "prover9_expression": "(creates_agency(fda) -> authorized_research(institution))",
        "natural": "If the FDA is created as an agency, then the institution is authorized for research."
      },
      "(A16 → A15)": {
        "formal": "(A16 → A15)",
        "prover9": "(A16 -> A15)",
        "prover9_expression": "(establishes_guidelines(fda) -> creates_agency(fda))",
        "natural": "Provided that the FDA establishes guidelines, then the FDA is created as an agency."
      },
      "(A17 → A18)": {
        "formal": "(A17 → A18)",
        "prover9": "(A17 -> A18)",
        "prover9_expression": "(has_patent(pharma_company) -> exclusive_rights(pharma_company))",
        "natural": "Under the condition that the pharma company has a patent, it has exclusive rights."
      },
      "(A17 → G)": {
        "formal": "(A17 → G)",
        "prover9": "(A17 -> G)",
        "prover9_expression": "(has_patent(pharma_company) -> drug_approved(drug_x))",
        "natural": "Whenever the pharma company has a patent, drug X is approved."
      },
      "(A18 → G)": {
        "formal": "(A18 → G)",
        "prover9": "(A18 -> G)",
        "prover9_expression": "(exclusive_rights(pharma_company) -> drug_approved(drug_x))",
        "natural": "If the pharma company has exclusive rights, then drug X is approved."
      },
      "(A19 → A20)": {
        "formal": "(A19 → A20)",
        "prover9": "(A19 -> A20)",
        "prover9_expression": "(illegal_import(supplier) -> registered_importer(supplier))",
        "natural": "Provided that the supplier engages in illegal import, then the supplier is a registered importer."
      },
      "(A19 → A21)": {
        "formal": "(A19 → A21)",
        "prover9": "(A19 -> A21)",
        "prover9_expression": "(illegal_import(supplier) -> customs_seizure(shipment))",
        "natural": "Under the condition that the supplier engages in illegal import, the shipment is subject to customs seizure."
      },
      "(A19 → A22)": {
        "formal": "(A19 → A22)",
        "prover9": "(A19 -> A22)",
        "prover9_expression": "(illegal_import(supplier) -> investigation_opened(fbi))",
        "natural": "If the supplier engages in illegal import, then the FBI opens an investigation."
      },
      "(A19 → A23)": {
        "formal": "(A19 → A23)",
        "prover9": "(A19 -> A23)",
        "prover9_expression": "(illegal_import(supplier) -> criminal_charges(filed))",
        "natural": "Whenever the supplier engages in illegal import, criminal charges are filed."
      },
      "(A19 → ¬A20)": {
        "formal": "(A19 → ¬A20)",
        "prover9": "(A19 -> -A20)",
        "prover9_expression": "(illegal_import(supplier) -> -registered_importer(supplier))",
        "natural": "Provided that the supplier engages in illegal import, then it is not the case that the supplier is a registered importer."
      },
      "(A19 ∨ (A17 → A18))": {
        "formal": "(A19 ∨ (A17 → A18))",
        "prover9": "(A19 | (A17 -> A18))",
        "prover9_expression": "(illegal_import(supplier) | (has_patent(pharma_company) -> exclusive_rights(pharma_company)))",
        "natural": "Either the supplier engages in illegal import or, if the pharma company has a patent, then it has exclusive rights."
      },
      "(A21 → ¬A20)": {
        "formal": "(A21 → ¬A20)",
        "prover9": "(A21 -> -A20)",
        "prover9_expression": "(customs_seizure(shipment) -> -registered_importer(supplier))",
        "natural": "Under the condition that the shipment is subject to customs seizure, then the supplier is not a registered importer."
      },
      "(A22 → A21)": {
        "formal": "(A22 → A21)",
        "prover9": "(A22 -> A21)",
        "prover9_expression": "(investigation_opened(fbi) -> customs_seizure(shipment))",
        "natural": "If the FBI opens an investigation, then the shipment is subject to customs seizure."
      },
      "(A23 → A22)": {
        "formal": "(A23 → A22)",
        "prover9": "(A23 -> A22)",
        "prover9_expression": "(criminal_charges(filed) -> investigation_opened(fbi))",
        "natural": "Provided that criminal charges are filed, then the FBI opens an investigation."
      },
      "(A24 → G)": {
        "formal": "(A24 → G)",
        "prover9": "(A24 -> G)",
        "prover9_expression": "(clinical_trial_phase(completed) -> drug_approved(drug_x))",
        "natural": "Under the condition that the clinical trial phase is completed, then drug X is approved."
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(clinical_trial_phase(completed) | peer_review_passed(study))",
        "natural": "Either the clinical trial phase is completed or the study passes peer review."
      },
      "(A25 → G)": {
        "formal": "(A25 → G)",
        "prover9": "(A25 -> G)",
        "prover9_expression": "(peer_review_passed(study) -> drug_approved(drug_x))",
        "natural": "Whenever the study passes peer review, drug X is approved."
      },
      "(A26 → (A24 → G))": {
        "formal": "(A26 → (A24 → G))",
        "prover9": "(A26 -> (A24 -> G))",
        "prover9_expression": "(data_audit(independent) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
        "natural": "If an independent data audit is conducted, then, provided that the clinical trial phase is completed, drug X is approved."
      },
      "(A26 ∨ A27)": {
        "formal": "(A26 ∨ A27)",
        "prover9": "(A26 | A27)",
        "prover9_expression": "(data_audit(independent) | statistical_analysis(valid))",
        "natural": "Either an independent data audit is conducted or the statistical analysis is valid."
      },
      "(A27 → (A24 → G))": {
        "formal": "(A27 → (A24 → G))",
        "prover9": "(A27 -> (A24 -> G))",
        "prover9_expression": "(statistical_analysis(valid) -> (clinical_trial_phase(completed) -> drug_approved(drug_x)))",
        "natural": "Under the condition that the statistical analysis is valid, then, if the clinical trial phase is completed, drug X is approved."
      },
      "(A28 → A26)": {
        "formal": "(A28 → A26)",
        "prover9": "(A28 -> A26)",
        "prover9_expression": "(monitoring_committee(review) -> data_audit(independent))",
        "natural": "Provided that the monitoring committee conducts a review, then an independent data audit is conducted."
      },
      "(A28 ∨ A29)": {
        "formal": "(A28 ∨ A29)",
        "prover9": "(A28 | A29)",
        "prover9_expression": "(monitoring_committee(review) | adverse_events(reported))",
        "natural": "Either the monitoring committee conducts a review or adverse events are reported."
      },
      "(A29 → A27)": {
        "formal": "(A29 → A27)",
        "prover9": "(A29 -> A27)",
        "prover9_expression": "(adverse_events(reported) -> statistical_analysis(valid))",
        "natural": "If adverse events are reported, then the statistical analysis is valid."
      },
      "(A29 → A30)": {
        "formal": "(A29 → A30)",
        "prover9": "(A29 -> A30)",
        "prover9_expression": "(adverse_events(reported) -> safety_assessment(completed))",
        "natural": "Whenever adverse events are reported, a safety assessment is completed."
      },
      "(A30 → A27)": {
        "formal": "(A30 → A27)",
        "prover9": "(A30 -> A27)",
        "prover9_expression": "(safety_assessment(completed) -> statistical_analysis(valid))",
        "natural": "Under the condition that a safety assessment is completed, then the statistical analysis is valid."
      },
      "(A32 → A31)": {
        "formal": "(A32 → A31)",
        "prover9": "(A32 -> A31)",
        "prover9_expression": "(protocol_amendment(required) -> trial_suspended(temporarily))",
        "natural": "Provided that a protocol amendment is required, then the trial is suspended temporarily."
      },
      "(A33 → (¬(A29 → A30) → A32))": {
        "formal": "(A33 → (¬(A29 → A30) → A32))",
        "prover9": "(A33 -> (-(A29 -> A30) -> A32))",
        "prover9_expression": "(dsmb_recommendation(issued) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
        "natural": "If a DSMB recommendation is issued, then, under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required."
      },
      "(A33 ∨ A34)": {
        "formal": "(A33 ∨ A34)",
        "prover9": "(A33 | A34)",
        "prover9_expression": "(dsmb_recommendation(issued) | regulatory_inspection(fda))",
        "natural": "Either a DSMB recommendation is issued or the FDA conducts a regulatory inspection."
      },
      "(A34 → (¬(A29 → A30) → A32))": {
        "formal": "(A34 → (¬(A29 → A30) → A32))",
        "prover9": "(A34 -> (-(A29 -> A30) -> A32))",
        "prover9_expression": "(regulatory_inspection(fda) -> (-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required)))",
        "natural": "Whenever the FDA conducts a regulatory inspection, then, provided that it is not the case that if adverse events are reported then a safety assessment is completed, a protocol amendment is required."
      },
      "(A36 ∨ ¬A35)": {
        "formal": "(A36 ∨ ¬A35)",
        "prover9": "(A36 | -A35)",
        "prover9_expression": "(quality_control_check(failed) | -manufacturing_complaint(received))",
        "natural": "Either the quality control check fails or it is not the case that a manufacturing complaint is received."
      },
      "(A37 ∨ ¬A36)": {
        "formal": "(A37 ∨ ¬A36)",
        "prover9": "(A37 | -A36)",
        "prover9_expression": "(batch_recall(initiated) | -quality_control_check(failed))",
        "natural": "Either a batch recall is initiated or it is not the case that the quality control check fails."
      },
      "(A38 ∨ ¬A37)": {
        "formal": "(A38 ∨ ¬A37)",
        "prover9": "(A38 | -A37)",
        "prover9_expression": "(production_halted(facility) | -batch_recall(initiated))",
        "natural": "Either production is halted at the facility or it is not the case that a batch recall is initiated."
      },
      "(A39 → ¬A8)": {
        "formal": "(A39 → ¬A8)",
        "prover9": "(A39 -> -A8)",
        "prover9_expression": "(false_claim_made(company) -> -violates_regulation(company))",
        "natural": "If the company makes a false claim, then it is not the case that the company violates a regulation."
      },
      "(A42 → (¬(¬A39 → A40) → A41))": {
        "formal": "(A42 → (¬(¬A39 → A40) → A41))",
        "prover9": "(A42 -> (-(-A39 -> A40) -> A41))",
        "prover9_expression": "(whistleblower_report(submitted) -> (-(-false_claim_made(company) -> corrective_action(taken)) -> warning_letter(issued)))",
        "natural": "Provided that a whistleblower report is submitted, then, under the condition that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, a warning letter is issued."
      },
      "(A5 → (¬(¬(¬(¬G → A1) → A2) → ¬A3) → A4))": {
        "formal": "(A5 → (¬(¬(¬(¬G → A1) → A2) → ¬A3) → A4))",
        "prover9": "(A5 -> (-(-(-(-G -> A1) -> A2) -> -A3) -> A4))",
        "prover9_expression": "(is_scheduled(hearing) -> (-(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee)) -> gets_market_approval(drug_x)))",
        "natural": "If a hearing is scheduled, then, under the condition that it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, drug X gets market approval."
      },
      "(A7 ∨ (¬G → ¬A6))": {
        "formal": "(A7 ∨ (¬G → ¬A6))",
        "prover9": "(A7 | (-G -> -A6))",
        "prover9_expression": "(submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab)))",
        "natural": "Either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
      },
      "(A8 → A9)": {
        "formal": "(A8 → A9)",
        "prover9": "(A8 -> A9)",
        "prover9_expression": "(violates_regulation(company) -> pays_fine(company))",
        "natural": "Whenever the company violates a regulation, then the company pays a fine."
      },
      "(A8 → ¬A9)": {
        "formal": "(A8 → ¬A9)",
        "prover9": "(A8 -> -A9)",
        "prover9_expression": "(violates_regulation(company) -> -pays_fine(company))",
        "natural": "Under the condition that the company violates a regulation, then it is not the case that the company pays a fine."
      },
      "(A8 ∨ (A7 ∨ (¬G → ¬A6)))": {
        "formal": "(A8 ∨ (A7 ∨ (¬G → ¬A6)))",
        "prover9": "(A8 | (A7 | (-G -> -A6)))",
        "prover9_expression": "(violates_regulation(company) | (submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))))",
        "natural": "Either the company violates a regulation or either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing."
      },
      "(¬(A29 → A30) → A31)": {
        "formal": "(¬(A29 → A30) → A31)",
        "prover9": "(-(A29 -> A30) -> A31)",
        "prover9_expression": "(-(adverse_events(reported) -> safety_assessment(completed)) -> trial_suspended(temporarily))",
        "natural": "Provided that it is not the case that if adverse events are reported then a safety assessment is completed, then the trial is suspended temporarily."
      },
      "(¬(A29 → A30) → A32)": {
        "formal": "(¬(A29 → A30) → A32)",
        "prover9": "(-(A29 -> A30) -> A32)",
        "prover9_expression": "(-(adverse_events(reported) -> safety_assessment(completed)) -> protocol_amendment(required))",
        "natural": "If it is not the case that if adverse events are reported then a safety assessment is completed, then a protocol amendment is required."
      },
      "(¬(A29 → A30) → ¬A31)": {
        "formal": "(¬(A29 → A30) → ¬A31)",
        "prover9": "(-(A29 -> A30) -> -A31)",
        "prover9_expression": "(-(adverse_events(reported) -> safety_assessment(completed)) -> -trial_suspended(temporarily))",
        "natural": "Under the condition that it is not the case that if adverse events are reported then a safety assessment is completed, then it is not the case that the trial is suspended temporarily."
      },
      "(¬(A7 ∨ (¬G → ¬A6)) → A35)": {
        "formal": "(¬(A7 ∨ (¬G → ¬A6)) → A35)",
        "prover9": "(-(A7 | (-G -> -A6)) -> A35)",
        "prover9_expression": "(-(submits_report(manufacturer) | (-drug_approved(drug_x) -> -completes_testing(lab))) -> manufacturing_complaint(received))",
        "natural": "Provided that it is not the case that either the manufacturer submits a report or, if drug X is not approved, then it is not the case that the lab completes testing, then a manufacturing complaint is received."
      },
      "(¬(¬(¬(¬G → A1) → A2) → ¬A3) → A4)": {
        "formal": "(¬(¬(¬(¬G → A1) → A2) → ¬A3) → A4)",
        "prover9": "(-(-(-(-G -> A1) -> A2) -> -A3) -> A4)",
        "prover9_expression": "(-(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee)) -> gets_market_approval(drug_x))",
        "natural": "If it is not the case that if it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data then the committee does not pass review, then drug X gets market approval."
      },
      "(¬(¬(¬G → A1) → A2) → A3)": {
        "formal": "(¬(¬(¬G → A1) → A2) → A3)",
        "prover9": "(-(-(-G -> A1) -> A2) -> A3)",
        "prover9_expression": "(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> passes_review(committee))",
        "natural": "Under the condition that it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then the committee passes review."
      },
      "(¬(¬(¬G → A1) → A2) → ¬A3)": {
        "formal": "(¬(¬(¬G → A1) → A2) → ¬A3)",
        "prover9": "(-(-(-G -> A1) -> A2) -> -A3)",
        "prover9_expression": "(-(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x)) -> -passes_review(committee))",
        "natural": "Whenever it is not the case that if it is not the case that if drug X is approved then clinical trials require approval then drug X has safety data, then it is not the case that the committee passes review."
      },
      "(¬(¬A39 → A40) → A41)": {
        "formal": "(¬(¬A39 → A40) → A41)",
        "prover9": "(-(-A39 -> A40) -> A41)",
        "prover9_expression": "(-(-false_claim_made(company) -> corrective_action(taken)) -> warning_letter(issued))",
        "natural": "Provided that it is not the case that if it is not the case that the company makes a false claim then corrective action is taken, then a warning letter is issued."
      },
      "(¬(¬G → A1) → A2)": {
        "formal": "(¬(¬G → A1) → A2)",
        "prover9": "(-(-G -> A1) -> A2)",
        "prover9_expression": "(-(-drug_approved(drug_x) -> requires_approval(clinical_trial)) -> has_safety_data(drug_x))",
        "natural": "If it is not the case that if drug X is approved then clinical trials require approval, then drug X has safety data."
      },
      "(¬A39 → A40)": {
        "formal": "(¬A39 → A40)",
        "prover9": "(-A39 -> A40)",
        "prover9_expression": "(-false_claim_made(company) -> corrective_action(taken))",
        "natural": "Under the condition that it is not the case that the company makes a false claim, then corrective action is taken."
      },
      "(¬A39 → ¬A40)": {
        "formal": "(¬A39 → ¬A40)",
        "prover9": "(-A39 -> -A40)",
        "prover9_expression": "(-false_claim_made(company) -> -corrective_action(taken))",
        "natural": "Whenever it is not the case that the company makes a false claim, then it is not the case that corrective action is taken."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-drug_approved(drug_x) -> requires_approval(clinical_trial))",
        "natural": "Provided that drug X is not approved, then clinical trials require approval."
      },
      "(¬G → A6)": {
        "formal": "(¬G → A6)",
        "prover9": "(-G -> A6)",
        "prover9_expression": "(-drug_approved(drug_x) -> completes_testing(lab))",
        "natural": "If drug X is not approved, then the lab completes testing."
      },
      "(¬G → ¬A6)": {
        "formal": "(¬G → ¬A6)",
        "prover9": "(-G -> -A6)",
        "prover9_expression": "(-drug_approved(drug_x) -> -completes_testing(lab))",
        "natural": "Under the condition that drug X is not approved, then it is not the case that the lab completes testing."
      },
      "A17": {
        "formal": "A17",
        "prover9": "A17",
        "prover9_expression": "has_patent(pharma_company)",
        "natural": "The pharma company has a patent."
      },
      "A39": {
        "formal": "A39",
        "prover9": "A39",
        "prover9_expression": "false_claim_made(company)",
        "natural": "The company makes a false claim."
      },
      "A42": {
        "formal": "A42",
        "prover9": "A42",
        "prover9_expression": "whistleblower_report(submitted)",
        "natural": "A whistleblower report is submitted."
      },
      "A5": {
        "formal": "A5",
        "prover9": "A5",
        "prover9_expression": "is_scheduled(hearing)",
        "natural": "A hearing is scheduled."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "drug_approved(drug_x)",
        "natural": "Drug X is approved."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-requires_approval(clinical_trial)",
        "natural": "It is not the case that clinical trials require approval."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-illegal_import(supplier)",
        "natural": "It is not the case that the supplier engages in illegal import."
      },
      "¬A2": {
        "formal": "¬A2",
        "prover9": "-A2",
        "prover9_expression": "-has_safety_data(drug_x)",
        "natural": "It is not the case that drug X has safety data."
      },
      "¬A35": {
        "formal": "¬A35",
        "prover9": "-A35",
        "prover9_expression": "-manufacturing_complaint(received)",
        "natural": "It is not the case that a manufacturing complaint is received."
      },
      "¬A36": {
        "formal": "¬A36",
        "prover9": "-A36",
        "prover9_expression": "-quality_control_check(failed)",
        "natural": "It is not the case that the quality control check fails."
      },
      "¬A37": {
        "formal": "¬A37",
        "prover9": "-A37",
        "prover9_expression": "-batch_recall(initiated)",
        "natural": "It is not the case that a batch recall is initiated."
      },
      "¬A38": {
        "formal": "¬A38",
        "prover9": "-A38",
        "prover9_expression": "-production_halted(facility)",
        "natural": "It is not the case that production is halted at the facility."
      },
      "¬A4": {
        "formal": "¬A4",
        "prover9": "-A4",
        "prover9_expression": "-gets_market_approval(drug_x)",
        "natural": "It is not the case that drug X gets market approval."
      },
      "¬A41": {
        "formal": "¬A41",
        "prover9": "-A41",
        "prover9_expression": "-warning_letter(issued)",
        "natural": "It is not the case that a warning letter is issued."
      },
      "¬A7": {
        "formal": "¬A7",
        "prover9": "-A7",
        "prover9_expression": "-submits_report(manufacturer)",
        "natural": "It is not the case that the manufacturer submits a report."
      },
      "¬A8": {
        "formal": "¬A8",
        "prover9": "-A8",
        "prover9_expression": "-violates_regulation(company)",
        "natural": "It is not the case that the company violates a regulation."
      }
    }
  }
}